About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
293 genotypes with 300 annotations displayed of selected term and subterms
Searched Term: abnormal hypodermis morphology
Allelic Composition
(Genetic Background)
Annotated Term Reference
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
decreased subcutaneous adipose tissue amount J:68427
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Adamts17tm1.2Taks/Adamts17tm1.2Taks
(involves: C57BL * C57BL/6 * DBA)
decreased subcutaneous adipose tissue amount J:295274
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
absent subcutaneous adipose tissue J:146649
Akt1tm1Hem/Akt1tm1Hem
(involves: 129P2/OlaHsd)
thin hypodermis J:96826
Aktiptm1a(EUCOMM)Hmgu/Aktiptm1a(EUCOMM)Hmgu
(C57BL/6N-Aktiptm1a(EUCOMM)Hmgu)
decreased subcutaneous adipose tissue amount J:276210
Aldh18a1tm1a(KOMP)Wtsi/Aldh18a1+
(C57BL/6N-Aldh18a1tm1a(KOMP)Wtsi/Wtsi)
abnormal hypodermis fat layer morphology J:232539
Alkal2tm1a(EUCOMM)Hmgu/Alkal2tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
decreased subcutaneous adipose tissue amount J:324631
Alkal2tm1Schl/Alkal2tm1Schl
(involves: C57BL/6)
decreased subcutaneous adipose tissue amount J:324631
Alo2/Alo2
(involves: C3H/HeJ * C57BL/6J)
abnormal hypodermis morphology J:109802
Alo2/Alo2+
(involves: C3H/HeJ * C57BL/6J)
abnormal hypodermis morphology J:109802
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo)
decreased subcutaneous adipose tissue amount J:152387
Ap1s2tm1Pschu/Y
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:216244
Ap1s2tm1Pschu/Ap1s2tm1Pschu
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:216244
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac * C57BL/6)
absent subcutaneous adipose tissue J:119516
Arhgap5tm1Jset/Arhgap5tm1Jset
(involves: 129S2/SvPas * C57BL/6J)
decreased subcutaneous adipose tissue amount J:83120
Arhgap31tm1.2Itl/Arhgap31tm1.2Itl
(involves: 129/SvEv * C57BL/6)
subcutaneous edema J:253757
Arid2tm1a(EUCOMM)Wtsi/Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
subcutaneous edema J:223458
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
decreased subcutaneous adipose tissue amount J:241193
Atf2tm1Sis/Atf2+
Creb5tm1Sis/Creb5+

(involves: C57BL/6 * CBA)
decreased subcutaneous adipose tissue amount J:156376
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0

(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
decreased subcutaneous adipose tissue amount J:231262
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc)
decreased subcutaneous adipose tissue amount J:222034
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Atrtm1Bal/Atrtm2Bal
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
decreased subcutaneous adipose tissue amount J:123200
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J)
decreased subcutaneous adipose tissue amount J:37846
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
ba/ba
(Swiss albino stock)
thick hypodermis J:291
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
decreased subcutaneous adipose tissue amount J:144416
Baiap2Gt(XG757)Byg/Baiap2Gt(XG757)Byg
(B6.129P2-Baiap2Gt(XG757)Byg)
subcutaneous edema J:275147
Baiap2Gt(XG757)Byg/Baiap2Gt(XG757)Byg
Baiap2l1tm1.1Arte/Baiap2l1tm1.1Arte

(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac)
subcutaneous edema J:275147
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6 * FVB/NJ)
increased subcutaneous adipose tissue amount J:271078
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
Ins2Akita/Ins2+

(B6.Cg-Ins2Akita Bdkrb2tm1Jfh)
decreased subcutaneous adipose tissue amount J:108948
Bgntm1Mfy/Y
Dcntm1Ioz/Dcntm1Ioz

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
thin hypodermis J:91512
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
decreased subcutaneous adipose tissue amount J:110697
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53tm1Brd/Trp53+

(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
decreased subcutaneous adipose tissue amount J:81559
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
decreased subcutaneous adipose tissue amount J:155810
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
subcutaneous edema J:239583
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
decreased subcutaneous adipose tissue amount J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
abnormal hypodermis fat layer morphology J:173404
decreased subcutaneous adipose tissue amount J:173404
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6N * FVB/NJ)
decreased subcutaneous adipose tissue amount J:260853
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac)
decreased subcutaneous adipose tissue amount J:91128
Bub1btm2.1Jvd/Bub1b+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
decreased subcutaneous adipose tissue amount J:194926
Bub3tm1Jvd/Bub3+
Rae1tm1Jvd/Rae1+

(Not Specified)
decreased subcutaneous adipose tissue amount J:105717
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
decreased subcutaneous adipose tissue amount J:241403
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
subcutaneous edema J:242127
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
absent subcutaneous adipose tissue J:75192
decreased subcutaneous adipose tissue amount J:75192
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
thin hypodermis J:105571
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
decreased subcutaneous adipose tissue amount J:147413
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
decreased subcutaneous adipose tissue amount J:220560
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp)
decreased subcutaneous adipose tissue amount J:332421
Cdc73tm1Btt/Cdc73tm1Btt
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129S4/SvJae * C57BL/6 * CBA)
decreased subcutaneous adipose tissue amount J:135255
Cdk7Gt(D032B11)1.1Wrst/Cdk7Gt(D032B11)1.1Wrst
Ndor1Tg(UBC-cre/ERT2)1Ejb/0

(involves: 129S/SvPas * 129S2/SvPas * C57BL/6 * SJL)
decreased subcutaneous adipose tissue amount J:183925
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
decreased subcutaneous adipose tissue amount J:195460
Cfap53em1(IMPC)Wtsi/Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi)
subcutaneous edema J:239583
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6J)
absent subcutaneous adipose tissue J:137079
decreased subcutaneous adipose tissue amount J:137079
Chtoptm1a(EUCOMM)Wtsi/Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka)
decreased subcutaneous adipose tissue amount J:140863
Cidectm1Pli/Cidectm1Pli
(Not Specified)
decreased subcutaneous adipose tissue amount J:140122
Cir1tm3a(KOMP)Wtsi/Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
decreased subcutaneous adipose tissue amount J:148467
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
decreased subcutaneous adipose tissue amount J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
decreased subcutaneous adipose tissue amount J:274297
Col4a2em1(IMPC)Wtsi/Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
subcutaneous edema J:239583
Col5a2tm1Rmz/Col5a2tm1Rmz
(either: (involves: 129S4/SvJae * 129T2/SvEms) or (involves: 129S4/SvJae * C57BL/6))
abnormal hypodermis morphology J:22301
thick hypodermis J:22301
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
decreased subcutaneous adipose tissue amount J:171817
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
subcutaneous edema J:239583
Crls1tm1Geno/Crls1tm1Geno
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6 * FVB/NJ)
decreased subcutaneous adipose tissue amount J:266083
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Asn/Cry2tm1Asn

(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:128437
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
increased subcutaneous adipose tissue amount J:102499
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Tg(Fabp4-cre)1Rev/0

(involves: 129P2/OlaHsd * C57BL/6)
increased subcutaneous adipose tissue amount J:217569
Cyfip2tm1a(EUCOMM)Wtsi/Cyfip2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cyfip2tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Del(16Lipi-Usp25)1Dja/+
(involves: 129P2/OlaHsd * C57BL/6)
increased subcutaneous adipose tissue amount J:184302
Dgat2tm1Lex/Dgat2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased subcutaneous adipose tissue amount J:103485
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
absent subcutaneous adipose tissue J:294620
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
decreased subcutaneous adipose tissue amount J:87402
Dsetm1Mmac/Dsetm1Mmac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal hypodermis morphology J:153897
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
decreased subcutaneous adipose tissue amount J:219200
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ)
decreased subcutaneous adipose tissue amount J:83117
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:147179
Efemp1tm2Lmar/Efemp1tm2Lmar
(involves: 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:132043
Efemp2tm1.1Chu/Efemp2tm1.1Chu
(B6(SJL)-Efemp2tm1.1Chu)
abnormal hypodermis muscle layer morphology J:223792
Efemp2tm1Dgen/Efemp2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hypodermis morphology J:106902
Efnb2tm2And/Efnb2tm2And
Tg(CAG-cre/Esr1*)1Egwa/0

(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
thin hypodermis J:157054
Egfrwa2/Egfrwa2
Ptpn11tm1Paw/Ptpn11+

(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6)
decreased subcutaneous adipose tissue amount J:75413
Ehbp1l1tm1a(EUCOMM)Wtsi/Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Epfq1L6/Epfq1L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq1L6/Epfq1M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Epfq2L6/Epfq2M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:41161
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
absent subcutaneous adipose tissue J:122058
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota)
decreased subcutaneous adipose tissue amount J:81609
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
decreased subcutaneous adipose tissue amount J:206074
Fbn1tm3.2Lysa/Fbn1+
(Not Specified)
decreased subcutaneous adipose tissue amount J:181493
Fbn1tm3.2Lysa/Fbn1tm3.2Lysa
(Not Specified)
decreased subcutaneous adipose tissue amount J:181493
Fbn1Tsk/Fbn1+
(B10.D2/(58N)Sn)
abnormal hypodermis morphology J:5629, J:6273
thick hypodermis J:6273
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
abnormal hypodermis morphology J:8047
Fbn1Tsk/Fbn1+
KitW/KitW-v

(involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ)
abnormal hypodermis morphology J:24076
Fgfr2tm1.1Dsn/Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6)
absent hypodermis muscle layer J:59285
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Lepob/Lepob
Tg(Fabp4-cre)1Rev/?

(involves: 129S6/SvEvTac * C57BL/6J)
decreased subcutaneous adipose tissue amount J:212437
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe)
decreased subcutaneous adipose tissue amount J:223365
Gabbr1tm1Dgen/Gabbr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
absent subcutaneous adipose tissue J:101679
Gata3tm3Gsv/Gata3tm3Gsv
Tg(KRT14-cre)8Brn/0

(involves: 129P2/OlaHsd * FVB/N)
absent subcutaneous adipose tissue J:117058
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
decreased subcutaneous adipose tissue amount J:191142
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
decreased subcutaneous adipose tissue amount J:176507
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi
Tg(Fabp4-cre)1Rev/0

(involves: C57BL/6N)
increased subcutaneous adipose tissue amount J:206358
Giptm1Nina/Giptm1Nina
(involves: C57BL/6)
decreased subcutaneous adipose tissue amount J:298236
Gm5544tm1a(KOMP)Wtsi/Gm5544tm1a(KOMP)Wtsi
(C57BL/6N-Gm5544tm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Gnastm1Gwa/Gnas+
(involves: 129S/SvEv * 129S4/SvJae)
abnormal hypodermis morphology J:174525
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0

(involves: FVB)
decreased subcutaneous adipose tissue amount J:159612
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0

(involves: C57BL/6 * FVB/N)
increased subcutaneous adipose tissue amount J:169459
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0

(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
decreased subcutaneous adipose tissue amount J:134135
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar)
increased subcutaneous adipose tissue amount J:178241
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6N * FVB/NJ)
decreased subcutaneous adipose tissue amount J:292236
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Hat1tm1.1Mrpa/Hat1+
(B6.Cg-Hat1tm1.1Mrpa)
decreased subcutaneous adipose tissue amount J:296531
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J)
decreased subcutaneous adipose tissue amount J:107145
Hmgxb3tm1a(EUCOMM)Wtsi/Hmgxb3tm1a(EUCOMM)Wtsi
(C57BL/6N-Hmgxb3tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
absent subcutaneous adipose tissue J:31627
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
absent subcutaneous adipose tissue J:31627
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
thin hypodermis J:101827
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N)
increased subcutaneous adipose tissue amount J:214146
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini)
decreased subcutaneous adipose tissue amount J:271356
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
absent subcutaneous adipose tissue J:63054
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
decreased subcutaneous adipose tissue amount J:108948
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified)
increased subcutaneous adipose tissue amount J:208931
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
decreased subcutaneous adipose tissue amount J:144968
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse)
decreased subcutaneous adipose tissue amount J:157001
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J)
decreased subcutaneous adipose tissue amount J:229255
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
decreased subcutaneous adipose tissue amount J:44109
Krt71Ca-Rin/?
(C57BL/6Slc-Krt71Ca-Rin)
decreased subcutaneous adipose tissue amount J:86407
LbrGt(XE569)Byg/LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
decreased subcutaneous adipose tissue amount J:138854
Lef1tm1Rug/Lef1tm1Rug
(involves: 129S2/SvPas * C57BL/6)
absent subcutaneous adipose tissue J:18378
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl)
increased subcutaneous adipose tissue amount J:313303
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl)
increased subcutaneous adipose tissue amount J:313303
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb)
increased subcutaneous adipose tissue amount J:313303
Leprtm1.1Chua/Leprtm1.1Chua
Prlhtm1(cre)Smln/Prlh+

(involves: 129 * C57BL/6J)
increased subcutaneous adipose tissue amount J:215557
Leprottm1.2Damj/Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N)
increased subcutaneous adipose tissue amount J:349250
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1)
absent subcutaneous adipose tissue J:68812
decreased subcutaneous adipose tissue amount J:68812
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
decreased subcutaneous adipose tissue amount J:133126
LmnaDhe/LmnaDhe
(B6(D2)-LmnaDhe/TyGrsrJ)
decreased subcutaneous adipose tissue amount J:160175
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
decreased subcutaneous adipose tissue amount J:221850
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:177632
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6NTac)
decreased subcutaneous adipose tissue amount J:261974
Lmnatm1Lgf/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:113119
Lmnatm2Stw/Lmnatm2Stw
(involves: 129S1/Sv)
absent subcutaneous adipose tissue J:83382
Lmnatm3Lgf/Lmnatm3Lgf
(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:141165
Lncpinttm1Vlcg/Lncpinttm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
decreased subcutaneous adipose tissue amount J:233815
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
increased subcutaneous adipose tissue amount J:307289
Lypd3tm1(KOMP)Vlcg/Lypd3tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
decreased subcutaneous adipose tissue amount J:235771
Lztfl1tm1e(KOMP)Wtsi/Lztfl1tm1e(KOMP)Wtsi
(involves: 129S/SvEv * C57BL/6N)
increased subcutaneous adipose tissue amount J:226512
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6)
decreased subcutaneous adipose tissue amount J:222253
Mapk8tm1Wag/Mapk8tm1Wag
(B6.129P2-Mapk8tm1Wag)
decreased subcutaneous adipose tissue amount J:80452
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
decreased subcutaneous adipose tissue amount J:192212
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
decreased subcutaneous adipose tissue amount J:192213
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
absent subcutaneous adipose tissue J:135368
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0

(involves: C57BL/6J * C57BL/6N * FVB/NJ)
decreased subcutaneous adipose tissue amount J:298822
Memo1tm1.1Neh/Memo1tm1.1Neh
Tg(CAG-cre/Esr1*)1Lbe/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
decreased subcutaneous adipose tissue amount J:206626
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6)
decreased subcutaneous adipose tissue amount J:190154
Mmp14tm1Stjw/Mmp14tm1Stjw
Twist2tm1.1(cre)Dor/Twist2+

(involves: 129X1/SvJ * C57BL/6)
abnormal hypodermis fat layer morphology J:198679
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
subcutaneous edema J:239583
Mpv17/Mpv17
(CFW-Mpv17/J)
abnormal hypodermis muscle layer morphology J:143355
decreased subcutaneous adipose tissue amount J:143355
Mpzl3tm1(KOMP)Mbp/Mpzl3tm1(KOMP)Mbp
(C57BL/6-Tyrc-Brd Mpzl3tm1(KOMP)Mbp)
decreased subcutaneous adipose tissue amount J:210832
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb)
decreased subcutaneous adipose tissue amount J:334467
Mybphltm1b(KOMP)Wtsi/Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Myo9atm1b(EUCOMM)Wtsi/Myo9atm1b(EUCOMM)Wtsi
(C57BL/6N-Myo9atm1b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu)
decreased subcutaneous adipose tissue amount J:332575
Npattm1b(EUCOMM)Wtsi/Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0

(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL)
decreased subcutaneous adipose tissue amount J:180396
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Nus1tm1Wcsa/Nus1tm1Wcsa
Tg(Cdh5-cre/ERT2)1Rha/0

(Not Specified)
subcutaneous edema J:230506
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
increased subcutaneous adipose tissue amount J:214124
Pbx1em1Dunw/Pbx1em1Dunw
(C57BL/6J-Pbx1em1Dunw)
subcutaneous edema J:320934
Pcbp2tm1.2Salr/Pcbp2tm1.2Salr
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * FVB/N)
subcutaneous edema J:235912
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+
Edil3Tg(Sox2-cre)1Amc/Edil3+

(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
abnormal hypodermis fat layer morphology J:173602
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+

(involves: 129X1/SvJ * C57BL/6)
abnormal hypodermis fat layer morphology J:226194
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:122399
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1tm2b(EUCOMM)Wtsi
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Pgftm1Pec/Pgftm1Pec
(involves: 129/Sv * Swiss)
decreased subcutaneous adipose tissue amount J:116580
Phf2tm1.1Yima/Phf2tm1.1Yima
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
decreased subcutaneous adipose tissue amount J:198329
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J)
decreased subcutaneous adipose tissue amount J:234657
Pkp1tm2d(KOMP)Wtsi/Pkp1tm2d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N * SJL/J)
decreased subcutaneous adipose tissue amount J:233599
Plin1tm1Cdl/Plin1tm1Cdl
(involves: 129S6/SvEvTac * C57BL/6)
decreased subcutaneous adipose tissue amount J:69629
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:66267
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg)
decreased subcutaneous adipose tissue amount J:196302
Pnliprp1tm1Smoc/Pnliprp1tm1Smoc
(involves: 129S/SvEv * C57BL/6)
increased subcutaneous adipose tissue amount J:278344
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm)
decreased subcutaneous adipose tissue amount J:333442
Polbtm1a(KOMP)Wtsi/Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Polgtm1.1Lrsn/Polgtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:91077
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh)
increased subcutaneous adipose tissue amount J:234615
Porcntm1.1Vdv/Y
Tg(KRT14-cre)1Efu/0

(involves: 129S4/SvJaeSor * 129S5/SvEvBrd * C57BL/6J)
abnormal hypodermis fat layer morphology J:186934
Pou3f2tm1Tno/Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
absent subcutaneous adipose tissue J:30429
Ppardtm1.1Rev/Ppardtm1.1Rev
(Not Specified)
decreased subcutaneous adipose tissue amount J:73557
Ppardtm1Wwah/Ppardtm1Wwah
(Not Specified)
thin hypodermis J:96826
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
absent subcutaneous adipose tissue J:125992
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:125992
Ppp6ctm1Shma/Ppp6ctm1Shma
Tg(KRT14-cre/ERT)20Efu/0

(involves: C57BL/6 * CBA * CD-1)
decreased subcutaneous adipose tissue amount J:231809
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Tg(Adipoq-cre)1Evdr/0

(involves: 129/Sv * C57BL/6 * FVB/N)
increased subcutaneous adipose tissue amount J:208683
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(TPO-cre)1Shk/0

(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
decreased subcutaneous adipose tissue amount J:225245
Prlhtm2Smln/Prlhtm2Smln
(involves: C57BL/6J)
increased subcutaneous adipose tissue amount J:215557
Prmt3tm1a(EUCOMM)Wtsi/Prmt3tm1a(EUCOMM)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Prmt3tm1a(EUCOMM)Wtsi/Wtsi)
abnormal hypodermis fat layer morphology J:232539
Prmt7tm1a(EUCOMM)Wtsi/Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
absent subcutaneous adipose tissue J:261081
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi)
subcutaneous edema J:239583, J:261316
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
decreased subcutaneous adipose tissue amount J:216593
Ptprdtm1Yiw/Ptprdtm1Yiw
Ptprstm1Mtr/Ptprstm1Mtr

(B6.Cg-Ptprdtm1Yiw Ptprstm1Mtr)
increased subcutaneous adipose tissue amount J:109122
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
decreased subcutaneous adipose tissue amount J:308336
Rassf9Tg(PDLIM7*)2Cml/Rassf9Tg(PDLIM7*)2Cml
(involves: ICR)
decreased subcutaneous adipose tissue amount J:171677
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
Pax3tm1(cre)Joe/0

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)
subcutaneous edema J:279139
Rln3tm1Lex/Rln3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
decreased subcutaneous adipose tissue amount J:181242
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Rps9tm1.1Geno/Rps9tm1.1Geno
(involves: C57BL/6)
decreased subcutaneous adipose tissue amount J:329922
Rxratm2Ipc/Rxratm4Ipc
Tg(KRT14-cre)1Ipc/0

(involves: 129S2/SvPas * C57BL/6 * SJL)
thin hypodermis J:67149
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
increased subcutaneous adipose tissue amount J:208616
Scfq1L6/Scfq1L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Scfq1L6/Scfq1M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Scfq3L6/Scfq3L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Scfq4L6/Scfq4L6
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Scfq4L6/Scfq4M16i
(involves: L6 * M16i)
decreased subcutaneous adipose tissue amount J:87793
Scn3btm1a(KOMP)Wtsi/Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi)
abnormal hypodermis muscle layer morphology J:232539
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
decreased subcutaneous adipose tissue amount J:87982
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex)
decreased subcutaneous adipose tissue amount J:194928
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Sh3kbp1tm1Ivdi/Sh3kbp1tm1Ivdi
(B6.129S-Sh3kbp1tm1Ivdi)
decreased subcutaneous adipose tissue amount J:162088
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Sh3pxd2bGt(GST_1527_E5)Lex/Sh3pxd2bGt(GST_1527_E5)Lex
(involves: 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:158635
Sh3pxd2btm1.1Arte/Sh3pxd2btm1.1Arte
(involves: C57BL/6NTac)
decreased subcutaneous adipose tissue amount J:235640
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N)
decreased subcutaneous adipose tissue amount J:183827
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
decreased subcutaneous adipose tissue amount J:112817
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * BALB/cJ)
decreased subcutaneous adipose tissue amount J:247143
Sirt6tm2.1Cxd/Sirt6tm2.1Cxd
(involves: 129S6/SvEvTac * NIH Black Swiss)
decreased subcutaneous adipose tissue amount J:167023
Sirt6tm2.2Cxd/Sirt6tm2.2Cxd
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
decreased subcutaneous adipose tissue amount J:167023
Sirt7tm1Evbo/Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6)
decreased subcutaneous adipose tissue amount J:147652
Slc13a4tm1a(EUCOMM)Wtsi/Slc13a4tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
subcutaneous edema J:239786
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(KRT5-cre)1Xya/0

(involves: 129S6/SvEvTac)
abnormal hypodermis morphology J:101602
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
absent subcutaneous adipose tissue J:104648
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu)
decreased subcutaneous adipose tissue amount J:257980
Sqstm1tm1Hwl/Sqstm1tm1Hwl
(B6.129P2-Sqstm1tm1Hwl)
decreased subcutaneous adipose tissue amount J:181228
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N)
decreased subcutaneous adipose tissue amount J:214131
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
increased subcutaneous adipose tissue amount J:187736
Stim1tm3Ics/Stim1+
(involves: C57BL/6N)
decreased subcutaneous adipose tissue amount J:277842
Sufutm1Hui/Sufutm1Hui
Tg(Fabp4-cre)1Rev/0

(involves: C57BL/6)
decreased subcutaneous adipose tissue amount J:166285
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
decreased subcutaneous adipose tissue amount J:144991
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0

(involves: 129P2/OlaHsd * C57BL/6)
decreased subcutaneous adipose tissue amount J:144991
Tent5ctm1b(KOMP)Wtsi/Tent5ctm1b(KOMP)Wtsi
(C57BL/6N-Tent5ctm1b(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Terctm1Rdp/Terctm1Rdp
Wrntm1Lgu/Wrntm1Lgu

(involves: 129/Sv * BALB/c * C57BL/6 * SLJ)
decreased subcutaneous adipose tissue amount J:91715
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N)
increased subcutaneous adipose tissue amount J:199372
Tfamtm1.1Ncdl/Tfamtm1.1Ncdl
Tg(KRT14-cre)1Amc/0

(involves: C57BL/6 * CBA)
decreased subcutaneous adipose tissue amount J:213840
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6)
increased subcutaneous adipose tissue amount J:249664
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
decreased subcutaneous adipose tissue amount J:249664
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh)
absent subcutaneous adipose tissue J:65036
Tg(CAG-PPARG*,-tdTomato)#Sig/0
Tg(Pomc1-cre)16Lowl/0

(involves: C57BL/6 * FVB/N * SJL)
increased subcutaneous adipose tissue amount J:242422
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
decreased subcutaneous adipose tissue amount J:129848
Tg(Fabp4-Fcor)1Jnak/0
(involves: C57BL/6 * DBA/2)
decreased subcutaneous adipose tissue amount J:184684
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc)
increased subcutaneous adipose tissue amount J:84349
Tg(Fabp4-LMNA*R482Q)#Hjw/0
(FVB.Cg-Tg(Fabp4-LMNA*R482Q)#Hjw)
abnormal hypodermis morphology J:237920
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1)
increased subcutaneous adipose tissue amount J:230172
Tg(HIV)26Aln/0
(involves: FVB/N)
subcutaneous edema J:90297
Tg(IGF1)1Jdg/0
(involves: FVB * ICR)
thick hypodermis J:39752
Tg(K6ODCtr)55Tgo/0
(involves: C3H * C57BL/6)
decreased subcutaneous adipose tissue amount J:29098
Tg(K6ODCtr)55Tgo/0
(C57BL/6-Tg(K6ODCtr)55Tgo/J)
decreased subcutaneous adipose tissue amount J:62356
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer/0

(involves: FVB/N)
abnormal hypodermis morphology J:145312
Tg(KRT14-PTHLH)7Wmp/0
(Not Specified)
decreased subcutaneous adipose tissue amount J:65043
Tg(Mup3-Plau)350-2Eps/0
(involves: C57BL/6 * FVB/N)
subcutaneous edema J:66132
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns)
subcutaneous edema J:133093
Tg(Myog-Ppargc1a_i4)#Brsp/0
(Not Specified)
decreased subcutaneous adipose tissue amount J:211329
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1)
decreased subcutaneous adipose tissue amount J:73757
Tgfb1tm1(Tgfb3)Kul/Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:204892
Tk2tm1Anka/Tk2tm1Anka
(involves: 129X1/SvJ * C57BL/6)
absent subcutaneous adipose tissue J:137664
Traf6tm2a(EUCOMM)Wtsi/Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi)
subcutaneous edema J:239583
Trim45tm1a(KOMP)Wtsi/Trim45tm1a(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Trim45tm1a(KOMP)Wtsi Tyrc-Brd/Wtsi)
subcutaneous edema J:239583
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
decreased subcutaneous adipose tissue amount J:73757
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ)
decreased subcutaneous adipose tissue amount J:137026
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj)
subcutaneous edema J:344151
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
absent subcutaneous adipose tissue J:81485
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129X1/SvJ * C57BL/6)
decreased subcutaneous adipose tissue amount J:169191
Unktm1a(KOMP)Wtsi/Unktm1a(KOMP)Wtsi
(C57BL/6N-Unktm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+

(involves: 129P2/OlaHsd * C57BL/6)
thin hypodermis J:202499
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
subcutaneous edema J:239583
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified)
absent subcutaneous adipose tissue J:33986
Zfp469em1Chms/Zfp469em1Chms
(C57BL/6J-Zfp469em1Chms)
decreased subcutaneous adipose tissue amount J:311083
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
absent subcutaneous adipose tissue J:76209
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/OlaHsd)
decreased subcutaneous adipose tissue amount J:164373
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
decreased subcutaneous adipose tissue amount J:79501

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory